NCT00238719View on ClinicalTrials.gov

Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

293

Participants

Timeline

Start Date

December 31, 1999

Study Completion Date

June 30, 2003

Conditions
Social Anxiety Disorder
Interventions
DRUG

Venlafaxine ER

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00238719 - Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder | Biotech Hunter | Biotech Hunter